fulvestrant has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boonyaratanakornkit, V; Edwards, DP; Lehrbach, GM; McGowan, EM; Musgrove, EA; Russell, AJ; Saunders, DN; Sergio, CM; Sutherland, RL | 1 |
1 other study(ies) available for fulvestrant and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
Article | Year |
---|---|
Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Interactions; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Pregnenediones; Progestins; Proto-Oncogene Proteins c-myc; Receptors, Progesterone; Transcription, Genetic | 2007 |